XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 4 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $221,000 | -26.8% | 198,888 | 0.0% | 0.02% | -66.7% |
| Q2 2022 | $302,000 | -35.9% | 198,888 | 0.0% | 0.07% | -51.7% |
| Q1 2022 | $471,000 | -14.5% | 198,888 | 0.0% | 0.14% | +5.1% |
| Q4 2021 | $551,000 | -36.7% | 198,888 | 0.0% | 0.14% | -33.7% |
| Q3 2021 | $871,000 | +9.7% | 198,888 | 0.0% | 0.20% | +3.5% |
| Q2 2021 | $794,000 | +19.9% | 198,888 | 0.0% | 0.20% | -8.3% |
| Q1 2021 | $662,000 | +9.8% | 198,888 | 0.0% | 0.22% | -12.9% |
| Q4 2020 | $603,000 | +59.5% | 198,888 | 0.0% | 0.25% | -1.2% |
| Q3 2020 | $378,000 | +19.6% | 198,888 | 0.0% | 0.25% | +11.1% |
| Q2 2020 | $316,000 | +35.0% | 198,888 | 0.0% | 0.23% | -45.9% |
| Q1 2020 | $234,000 | -14.0% | 198,888 | 0.0% | 0.42% | +37.0% |
| Q4 2019 | $272,000 | -4.9% | 198,888 | 0.0% | 0.30% | +1.3% |
| Q3 2019 | $286,000 | -28.1% | 198,888 | -0.0% | 0.30% | -38.3% |
| Q2 2019 | $398,000 | -15.1% | 198,889 | 0.0% | 0.49% | -0.2% |
| Q1 2019 | $469,000 | +36.3% | 198,889 | 0.0% | 0.49% | +69.8% |
| Q4 2018 | $344,000 | – | 198,889 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Noked Capital LTD | 198,888 | $794,000 | 0.20% |
| Noked Israel Ltd | 198,888 | $794,000 | 0.20% |
| SteelPeak Wealth, LLC | 11,671 | $47,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 54,064 | $216,000 | 0.00% |
| Renaissance Technologies | 37,187 | $148,000 | 0.00% |